Precision medicine for lung cancer is now allowing some patients to live for years with advanced disease, and better therapies are in the works.
Using an innovative algorithm, CUMC researchers have found that loss of a gene called KLHL9 is the driving force behind the most aggressive form of glioblastoma, the most common form of brain cancer.
A study that revealed the origins of the Askhenazi Jewish population will advance personalized medicine.
For a year, diabetes patient Doug Kanter tracked every blood sugar reading, every insulin dose, every meal, and all of his activity to produce the quintessential selfie.
Columbia surgeons and radiation oncologists deliver precise radiotherapy immediately following cancer tumor removal.
Columbia University Medical Center researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa, a leading cause of vision loss.